Combined Actions and Interactions of Chemicals in Mixtures

More documents

Recommendations

Info

Leeuwen FXR, Liem AKD, Nolt C, Peterson RE, Poellinger L, Safe S, Schrenck D, Tillitt D, Tysklind M, Younes M, Wærn F and Zacharewski T (1998). Toxic Equivalency Factors (TEFs) for PCBs, PCDDs, PCDFs for Humans and for Wildlife. Environ Health Perspec, 106, 775-792. Van Duuren BL, Melchionne S and Seidman I (1986). Phorbol myristate acetate and catechol as skin cocarcinogens in SENCAR mice. Environ Health Perspect, 68, 33-38. Van Goethem, Lison D and Kirsch-Volders M (1997). Comparative evaluation of the in vitro micronucleus test and the alkaline single cell gel electrophoresis assay for the detection of DNA damaging agents: genotoxic effects of cobalt powder, tungsten carbide and cobalt-tungsten carbide. Mutat Res, 392, 31-43. Veldman BA, Wijn AM, Knoers N, Praamstraa P and Horstink MW (1998). Genetic and environmental risk factors in Parkinson´s disease. Clin Neurol Neurosurg, 100, 15-26. Van’t Erve EHM, Wijnand E, Bol M, Seinen W and Pieters RHH (1998). The vehicle modulates cellular and humoral responses in contact hypersensitivity to oxazolone. Toxicol Sci, 44, 39-45. Verhaar HJM, Morroni JR, Reardon KF, Hays SM, Gaver DP, Carpenter RL and Yang RSH (1997). A proposed approach to study the toxicology of complex mixtures of petroleum products: the integrated used of QSAR, lumping analysis and PBPK/PD modelling. Environ Health Perspect, 105, 179-195. Vermeire T, Stevenson H, Pieters MN, Rennen M, Slob W and Hakkert BC (1999). Assessment factors for human health: A discussion paper. Crit Rev Toxicol, 29(5), 439-490. Verra F, Escudier E, Lebargy F, Bernaudin JF, De Cremoux H and Bignon J (1995). Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med, 151, 630-634. Verschaeve L, Van Gompel J, Thilemans L, Regniers L, Vanparys P and van der Lelie D (1999). VITOTOX bacterial genotoxicity and toxicity test for the rapid screening of chemicals. Environ Mol Mutagen, 33, 240-248. Vos JG, De Heer C and Van Loveren H (1997). Immunotoxic effects of TCDD and toxic equivalency factors. Teratog Carcinog Mutagen, 17, 275-84. Voskoboinik I, Drew R and Ahokas JT (1997). Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells. Chem Biol Interact, 105, 81-97. Wade MG, Desaulniers D, Leingartner K, and Foster WG (1997). Interactions between endosulfan and dieldrin on estrogen-mediated processes in vitro and in vivo. Reprod Toxicol, 11(6), 791-798. Wade MG, Foster WG, Younglai EV, McMahon AM, Leingartner K, Yagminas A, Blakey D, Fournier M, Desaulniers D and Hughes CL (2002). Effects of subchronic exposure to a complex mixture of persistent contaminants in male rats: systemic, immune, and reproductive effects. Toxicol Sci, 67, 131-143. Walum E, Srenberg K and Jenssen K (1990). Understanding cell toxicology. Principels and pratice. 1-142. Ellis Horwood, Chichester. 156
Wang C and Kurzer MS (1998). Effects of phytoestrogens on DNA synthesis in MCF7 cells in the presence of estradiol or growth factors. Nutrition and Cancer, 31(2), 90-100. Warshawsky D, Barkley W and Bingham E (1993). Factors affecting carcinogenic potential of mixtures. Fundam Appl Toxicol, 20, 376-382. Watson WS, Hume R and Moore MR (1980). Oral absorption of lead and iron. Lancet, 2, 236-237. Wattenberg LW (1980). Inhibitors of chemical carcinogens. J Environ Pathol Toxicol, 3, 35-52. Wattenberg LW (1996). Inhibition of tumorigenesis in animals. In: Stewart BW, McGregor D and Kleihues P (Eds.) Principles of chemoprevention. IARC Sci Publ, 139, 151-158. Weber H, Harris MW, Haseman JK and Birnbaum LS (1985). Teratogenic potency of TCDD, TCDF and TCDD-TCDF combinations in C57BL/6N mice. Toxicol Lett, 26, 159-167. Webster RP, Gawde MD and Bhattacharya RK (1996). Protective effect of rutin, a flavonol glycoside, on the carcinogen-induced DNA damage and repair enzymes in rats. Cancer Lett, 109, 185-191. Weill H, Georg R, Schwarz M and Ziskind M (1969). Late evaluation of pulmonary function after acute exposure to chlorine gas. Am Rev Respir Dis, 99, 374-379. Weiss B (1998). Neurobehavioral properties of chemical sensitivity syndromes. Neurotoxicol, 19, 259-268. Wester RC and Maibach HI (1985). Influence of hydration on percutaneous absorption. In: Percutaneous absorption. Mechanisms - Methodology - Drug Delivery. Eds: Bronaugh RL and Maibach HI. Marcel Dekker, Inc., New York, pp. 231-242. Whalan JE and Pettigrew HM (1997). Inhalation risk assessments and the combining of margins of exposure. U.S. Environmental Protection Agency, Office of Pesticide Programs, Washington, DC, February 10. WHO (1985). Organic solvent and the central nervous system. Environ Health, 5. World Health Organization and Nordic Council of Ministers. WHO (2000). Assessment of the health risk of dioxins: re-evaluation of the Tolerable Daily Intake (TDI). WHO Consultation May 25-29 1998, Geneva, Switzerland. WHO European Centre for Environment and Health and International Programme on chemical safety. World Health Organization, Geneva. Special Volume: Food Additives and Contaminants, 17. WHO (2001). WHO Air Quality Guidelines for Europe, 2nd Edition, World Health Organization, Regional Office for Europe, Copenhagen. Wilkinson CF, Christoph GR, Julien E, Kelley JM, Kronenburg J, McCarthy J and Reiss R (2000). Assessing the risks of exposure to multiple chemicals with a common mechanism of toxicity: How to cumulate? Reg Toxicol Pharmacol, 31, 30-43. 157
Page 1 and 2:
Combined Actions and Interactions o
Page 3 and 4:
Contents CONTENTS 3 PREFACE 6 SAMME
Page 5 and 6:
7.2.4 Test systems 85 7.2.5 In vitr
Page 7 and 8:
Sammenfatning og konklusioner Indle
Page 9 and 10:
er ingen viden om, hvorledes den ko
Page 11 and 12:
estemt biologisk respons (ED10, ED2
Page 13 and 14:
vivo. The COMET-assay in vivo and g
Page 15 and 16:
and antagonistic effects may be see
Page 17 and 18:
1 Introduction Prepared by John Chr
Page 19 and 20:
Table 1.3.1: Classification of comb
Page 21 and 22:
Physicochemical interactions will t
Page 23 and 24:
US EPA (1986) applied the concept o
Page 25 and 26:
2.4 Test strategies to assess combi
Page 27 and 28:
Figure 2.4.3.1. Isobologram of two
Page 29 and 30:
CI = d1 /D1 = 1 In this case the is
Page 31 and 32:
2.5 Toxicological test methods When
Page 33 and 34:
3 General concepts in the risk asse
Page 35 and 36:
NOAEL, this indicates that the subs
Page 37 and 38:
of uncertainty i.e. differences in
Page 39 and 40:
describe toxicities that appears to
Page 41 and 42:
should be estimated for all endpoin
Page 43 and 44:
1,2,3,6,7,8-HxCDF 0.1 1,2,3,7,8,9-H
Page 45 and 46:
shows the pronounced influence of t
Page 47 and 48:
Table 4.3.1 Estimates of carcinogen
Page 49 and 50:
Figure 4.4.1.1. Scheme for safety e
Page 51 and 52:
obvious ranking of individual const
Page 53 and 54:
4.5 Approach for assessment of join
Page 55 and 56:
4.6 Approaches currently used by re
Page 57 and 58:
no internationally accepted procedu
Page 59:
Figure 4.6.3.1 Flow chart of the ri
Page 62 and 63:
octyltin dichloride). A number of a
Page 64 and 65:
stannous chloride and cadmium chlor
Page 66 and 67:
seen in the animals from the 1000x
Page 68 and 69:
c TCTFP = 1,1,2-trichloro-3,3,3-tri
Page 70 and 71:
6 Interactions in toxicokinetics Pr
Page 72 and 73:
once more exposed and the kinetics
Page 74 and 75:
Dermis The dermis consists of a sup
Page 76 and 77:
7.1.3 Ocular irritancy 7.1.3.1 Comp
Page 78 and 79:
Another in vitro test for ocular ir
Page 80 and 81:
lipid peroxidation was observed, wh
Page 82 and 83:
mixture. These interactions may dev
Page 84 and 85:
0.6% of live births in humans. In s
Page 86 and 87:
DNA, and that the cell was capable
Page 88 and 89:
(Sorsa et al. 1994, Myslak & Kosmid
Page 90 and 91:
Four inhibitors of DNA topoisomeras
Page 92 and 93:
cyclophosphamide-metabolising enzym
Page 94 and 95:
Nickel compounds are carcinogenic t
Page 96 and 97:
7.2.8 Conclusion As shown in this r
Page 98 and 99:
Since no compounds are known to cau
Page 100 and 101:
In a more mechanistic sense, promot
Page 102 and 103:
Several inhibitors of tumour promot
Page 104 and 105:
Table 7.4.1.1 Overview of in vivo t
Page 106 and 107: analysis was used to predict the hi
Page 108 and 109: interaction of TCDD and retinoic ac
Page 110 and 111: and now includes compounds as diver
Page 112 and 113: Furthermore, the estrogenic effects
Page 114 and 115: Dose of A (arbitrary units) 10 8 6
Page 116 and 117: chance or experimental error. One w
Page 118 and 119: 7.6.2.3 Receptors A receptor is a b
Page 120 and 121: 7.6.5.2 Kindling Kindling is the ph
Page 122 and 123: Science Institute (RSI) have conven
Page 124 and 125: eaction with sulfhydryl groups). Th
Page 126 and 127: 7.7.1.3 Mechanisms of immunotoxicit
Page 128 and 129: tested separately. This is a phenom
Page 130 and 131: In practical life an allergen may b
Page 132 and 133: 8.3 Conference proceedings Proceedi
Page 134 and 135: with combinations of environmental
Page 136 and 137: Boyd MR, Statham CM and Longo NS (1
Page 138 and 139: De Wall EJ, Schuurman HJ and Van Lo
Page 140 and 141: theoretical considerations and a su
Page 142 and 143: Groten JP, Sinkeldam EJ, Muys T, Lu
Page 144 and 145: Howes D, Guy R, Hadgraft J, Heyling
Page 146 and 147: cytochrome P450 1A2 expressed in Am
Page 148 and 149: Lison D, Carbonnelle P, Mollo L, La
Page 150 and 151: Narotsky MG, Weller EA, Chinchilli
Page 152 and 153: Ramsey JC and Andersen ME (1984). A
Page 154 and 155: Silva E, Rajapakse N and Kortenkamp
Page 158: Wlodarczyk B, Biernacki B, Minta M,
show all

Combined Actions and Interactions of Chemicals in Mixtures

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?